MEK5 as a driver in lung cancer

Lung cancer is the most common human neoplasia, frequently associated to a dismal outcome. Unfortunately, in advanced stages no efficient therapies are available to fight this devastating disease. Therefore, knowledge of the driving pathophysiological processes is required to raise novel therapeutic strategies. In the work reported here we unveiled an oncogenic role for the protein kinase MEK5 in lung c